|
|
| Line 1: |
Line 1: |
| - | <html><head>
| |
| - | <style type=text/css>
| |
| - | {text-align: justify;}
| |
| - | .tblsample table, .tblsample tr, .tblsample td {border:0px;
| |
| - | cellpadding:5;
| |
| - | cellspacing:1;
| |
| - | bgcolor:none;
| |
| - | background:url();
| |
| | | | |
| - | }
| |
| - |
| |
| - | ul.acc, ul.acc li ul {
| |
| - | width 965px;
| |
| - | height autopx;
| |
| - | margin: 0;
| |
| - | padding: 0;
| |
| - | list-style: none;
| |
| - | }
| |
| - |
| |
| - | ul.acc a{
| |
| - | display: block;
| |
| - | height: 30px;
| |
| - | line-height: 30px;
| |
| - | color: #feffff;
| |
| - | }
| |
| - |
| |
| - | ul.acc {
| |
| - |
| |
| - | background-color: #185AAC;
| |
| - | }
| |
| - |
| |
| - | ul.acc li ul {
| |
| - | background-color: #A6B5E2;
| |
| - | }
| |
| - |
| |
| - | </style>
| |
| - | </head>
| |
| - |
| |
| - |
| |
| - |
| |
| - | <script type="text/javascript">
| |
| - | <!--
| |
| - | var j$ = jQuery;
| |
| - |
| |
| - | j$(function(){
| |
| - | j$(".acc").each(function(){
| |
| - | j$("li > a", this).each(function(index){
| |
| - | var $this = j$(this);
| |
| - |
| |
| - | if(index > 0) $this.next().hide();
| |
| - |
| |
| - | $this.click(function(){
| |
| - | var params = {height:"toggle", opacity:"toggle"};
| |
| - | j$(this).next().animate(params).parent().siblings()
| |
| - | .children("ul:visible").animate(params);
| |
| - | return false;
| |
| - | });
| |
| - | });
| |
| - | });
| |
| - | });
| |
| - |
| |
| - |
| |
| - | //-->
| |
| - | </script>
| |
| - |
| |
| - |
| |
| - |
| |
| - | </html>
| |
| | {{Template:KIT-Kyoto/menu}} | | {{Template:KIT-Kyoto/menu}} |
| | <table border=0 width="965px" align="center"><tr><td> | | <table border=0 width="965px" align="center"><tr><td> |
| | [[Team:KIT-Kyoto|Home]] > [[Team:KIT-Kyoto/Safety|Safety]]</td></tr></table> | | [[Team:KIT-Kyoto|Home]] > [[Team:KIT-Kyoto/Safety|Safety]]</td></tr></table> |
| - | {| class="tblsample" style="color:black;background-color:transparent;" cellpadding="0" cellspacing="15" border="0" bordercolor="#ccc" width="965px" align="center"
| + | <div id="NAKAMI"> |
| - | |
| + | |
| - | | + | |
| - | ==Questions==
| + | |
| - | There are 4 questions in [[Safety]].
| + | |
| - | | + | |
| - | ==Answers==
| + | |
| - | Q. Would any of your project ideas raise safety issues in terms of researcher safety, public safety, or environmental safety?
| + | |
| - | | + | |
| - | A. No issues of researcher safety, public safety or environmental safety raised up during our KIT-Kyoto iGEM 2010 project. All our work was performed fallowing the guidelines of the safety standards required by biosafety level 1. Rules of best microbiological practices were applied.
| + | |
| - | Our project ‘’E.coli Pen’’ enables an appreciator to take a pen, draw and color. Since ‘’E.coli Pen’’ has H<sub>2</sub>O<sub>2</sub> as bacterial killing means, it prevents transgenic E.coli from spreading. (See the article of E.coli survival curve by H<sub>2</sub>O<sub>2</sub> density.)
| + | |
| - | | + | |
| - | | + | |
| - | Q. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes, did you document these issues in the Registry? How did you manage to handle the safety issue? How could other teams learn from your experience?
| + | |
| - | | + | |
| - | A. No. We developed some parts of producing fluorescence protein used by H<sub>2</sub>O<sub>2</sub> responsive promoter. These parts are completely harmless.
| + | |
| - | | + | |
| - | | + | |
| - | Q. Is there a local biosafety group, committee, or review board at your institution? If yes, what does your local biosafety group think about your project? If no, which specific biosafety rules or guidelines do you have to consider in your country?
| + | |
| - | | + | |
| - | A. Yes. We have bio safety group at KIT, and our project has been monitored by them. The leader of this biological safety group was Prof Yamaguchi. Furthermore, there is an upper level committee of transgenic experiences at Kyoto Institute of Technology. Our project has also received accreditation from this committee.
| + | |
| - | All material handled or distributed are non-hazardous and non-infectious. It agrees with all safety standards requested by bio safety level 1. Therefore, Prof. Yamaguchi and other education stuff and Instructors fully support the work done by this iGEM team.
| + | |
| - | | + | |
| - | | + | |
| - | Q. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?
| + | |
| - | | + | |
| - | A. No, we don’t.
| + | |
| - | | + | |
| - | | + | |
| - | <!--【キムワイプの中心で愛を叫ぶ －その４－】
| + | |
| - | アクセス集中、リロード要求、数々の苦難を乗り越え、私はついに辿り着いた。
| + | |
| - | この登録フォームさえ入力してしまえば、私はこの紙のスポーツ協会の仲間入りなのである。
| + | |
| - | あと少し、この「あと少し」が待ち遠しくてたまらない。
| + | |
| - | しかし募る思いは山より高く、一向に入力の手が緩む気配が感じられない。
| + | |
| - | まさか、キムワイプへの愛がここで私を阻むことになろうとは夢にも思わなかった。-->
| + | |
| - | | + | |
| | | | |
| | | | |
| | + | </div> |
| | {{Template:KIT-Kyoto-1}} | | {{Template:KIT-Kyoto-1}} |
"
